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Abstract
Purpose Alterations in the urinary microbiome have been associated with urological diseases. The microbiome of patients 
with urethral stricture disease (USD) remains unknown. Our objective is to examine the microbiome of USD with a focus 
on inflammatory USD caused by lichen sclerosus (LS).
Methods We collected mid-stream urine samples from men with LS-USD (cases; n = 22) and non-LS USD (controls; n = 76). 
DNA extraction, PCR amplification of the V4 hypervariable region of the 16S rRNA gene, and sequencing was done on the 
samples. Operational taxonomic units (OTUs) were defined using a > 97% sequence similarity threshold. Alpha diversity 
measurements of diversity, including microbiome richness (number of different OTUs) and evenness (distribution of OTUs) 
were calculated and compared. Microbiome beta diversity (difference between microbial communities) relationships with 
cases and controls were also assessed.
Results Fifty specimens (13 cases and 37 controls) produced a 16S rRNA amplicon. Mean sample richness was 25.9 vs. 
16.8 (p = 0.076) for LS-USD vs. non-LS USD, respectively. LS-USD had a unique profile of bacteria by taxonomic order 
including Bacillales, Bacteroidales and Pasteurellales enriched urine. The beta variation of observed bacterial communities 
was best explained by the richness.
Conclusions Men with LS-USD may have a unique microbiologic richness, specifically inclusive of Bacillales, Bacteroi-
dales and Pasteurellales enriched urine compared to those with non-LS USD. Further work will be required to elucidate the 
clinical relevance of these variations in the urinary microbiome.
Keywords Urethral stricture disease · Lichen sclerosus · Microbiome · Urinary tract infection (UTI) · Colonization
Introduction
Mounting evidence suggests that the urinary tract harbors 
a unique microbiome, which encompasses the microorgan-
isms in a particular environment and their combined genetic 
material and may have an impact on lower urinary tract func-
tion [1–2]. A unique microbiome in women has recently 
been discovered [3], deepening our comprehension of com-
mon lower urinary tract ailments, including urinary incon-
tinence and urinary tract infection [4]. Likewise, the male 
urethra has been shown to harbor varied bacteria [5, 6]. The 
study of the male urinary microbiome remains in its infancy 
and relationships between lower urinary tract symptoms and 
variance in microbiota are not well established [2].
Alterations of the typical microbiome have been impli-
cated in chronic low-level inflammation throughout the body 
[7]. For example, perturbation to the composition or function 
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of the gut microbiome is associated with a wide range of dis-
ease such as arthritis, frailty, metabolic disease, neurologic 
disease, and inflammatory bowel conditions [8]. More recent 
studies have offered mechanistic insights into how altered 
microbiomes promote disease, highlighting microbial pro-
duction of bioactive small molecules as a relatively under-
appreciated mechanism by which microbiomes elicit their 
effect on host immunity [9]. The degree to which alterations 
in the urinary microbiome affect the male urinary tract or 
contribute to chronic genitourinary inflammation, however, 
is unknown.
One poorly understood inflammatory condition that nega-
tively impacts the male urethra is genitourinary lichen scle-
rosus (LS) [10]. LS is a chronic, inflammatory condition of 
unknown etiology that can result in urethral stricture disease 
(USD) [11]. USD incurs substantial morbidity and incurs 
high costs in affected men [12]. Infectious etiologies have 
been suggested as causative agents for LS [13]. Explorations 
of the urinary microbiome may shed light into the patho-
physiology of this complex disease.
Our objective was to determine the typical microbiota in 
patients with USD. Second, we aim to define whether asso-
ciations exist between microbiota and a special population 
of USD patients: those with LS. We hypothesize differences 
exist in microbial diversity and richness between patients 
with LS-associated USD compared to those with non-LS-
associated USD.
Methods
Patient population
Eligible patients were identified upon their presentation 
in clinic and prospectively recruited for inclusion without 
incentive. Inclusion criteria included men age > 18 years 
old, with suspected LS-USD (cases; n = 22) or non-LS 
USD (controls; n = 76) presenting for diagnosis and work-
up. Patients were excluded if they had recent genitourinary 
surgery/instrumentation (< 2 months prior to study sam-
ple collection), a recent symptomatic urinary tract infec-
tion (< 6 months) or took recent antibiotics (< 2 months). 
Patients were also excluded if they were HIV positive, and/
or on immunosuppressant or systemic steroid therapy, and/or 
had a systemic autoimmune disease (such as lupus, multiple 
sclerosis, glomerulonephritis, Graves’ disease, or rheuma-
toid arthritis). All patients underwent traditional urine cul-
ture as well as simultaneous urinary microbiome analysis. 
This study was approved by University of California, San 
Francisco Internal Review Board.
For those meeting inclusion criteria, we collected a 
mid-stream urine sample at time of the office visit, at least 
30 days before the procedure, prior to administration of any 
peri-procedural antibiotics or diagnostic studies. Patients 
with urine cultures resulting in > 100,000 colony forming 
units were later excluded. Men were characterized by pre-
senting phenotype as LS-USD (cases) or non-LS USD (con-
trols). A diagnosis of LS was suspected clinically based on 
physical exam findings by reconstructive expert (BB) and 
included: white skin changes on the glans, meatus, fusion of 
glans to foreskin, and/or LS urethral changes such as stippled 
or pan-urethral disease on retrograde urethrogram. A diag-
nosis of USD was suspected by patient reported symptoms 
of poor urinary flow, referral physician suspected diagnosis 
and confirmed by retrograde urethrogram. All LS patients 
included in this study, at the minimum, had meatal stenosis. 
Surgical treatment for USD or LS was not necessary for 
inclusion.
Urinary microbiome analysis
Urine samples underwent DNA extraction using an opti-
mized Cetyl trimethylammonium bromide (CTAB) method 
followed by PCR amplification of the V4 hypervariable 
region of the 16S rRNA gene, and sequencing on the Next-
Seq platform (Illumina, San Diego, California, USA) as pre-
viously described [14]. This was triplicated. Paired sequenc-
ing reads were quality filtered and clustered into operational 
taxonomic units (OTUs) using a 97% sequence similarity 
threshold while removing chimeras using the cluster_otus 
command in usearch (v8.0.1623). Read counts for OTUs 
detected at < 0.001% of the total read count were discarded 
to minimize noise in the dataset [15]. Sequence reads were 
representatively rarefied to 1000 reads per sample. Alpha 
diversity is a metric of mean species diversity in a particular 
environment, whereas the differentiation among the inhabit-
ants is beta diversity [16]. Alpha diversity (Shannon, Simp-
son, Inverse Simpson, and Faith’s phylogenetic diversity) 
indices of microbiota richness (number of different OTUs) 
and evenness (distribution of OTUs), were calculated using 
the vegan package in R. Beta diversity (Bray–Curtis dis-
similarity, Canberra distance, and weighted/unweighted 
UniFrac analysis) distances matrices were calculated in 
QIIME (Python script) [17] and visualized using principal 
coordinate analysis.
Statistical analyses
Alpha diversity metrics were compared using Student’s 
or Welch’s T test where appropriate. Permutational multi-
variate analysis of variance (PERMANOVA) was used to 
determine relationships between clinical phenotype and beta 
diversity. Taxon relative abundance comparisons were per-
formed using the three-model approach we have previously 
described, which accounts for varying data distributions and 
the zero-inflated nature of count-based microbiota sequence 
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datasets [14]. DESeq was used to determine sample enrich-
ment [17]. Patient characteristics were compared using Chi-
squared, fisher’s exact or t tests as appropriate. Stata 15 (Col-
lege Station, Texas, USA) and the R statistical environment 
were used for all statistical analysis. p values less than 0.05 
were considered statistically significant.
Results
Initially 98 patients were recruited: 22 cases and 76 con-
trols. Our population reflects our role as a tertiary referral 
center for the surgical management of USD with 34.7% of 
patients already having undergone at least one urethroplasty. 
Similarly, all comers with USD averaged three prior ure-
thral dilations. Among those included, a greater proportion 
of LS-USD patients versus non-LS USD patients (53.9% 
and 24.3%, respectively) had used antibiotics within the 
12 months prior to study recruitment, though this finding 
was not statistically significant (p = 0.08). Screening urine 
culture eliminated 16 patients from inclusion due to the 
presence of > 100,000 colony forming units on traditional 
urine culture. Fifty of the remaining 82 samples successfully 
produced a 16S rRNA amplicon for microbiota analyses. 
(Supplemental Fig. 1). Patients (LS-USD or non-LS USD) 
included in these analyses were similar with respect to age, 
IPSS, and procedural history (Table 1). Median BMI for the 
LS-USD patients was 32 [interquartile range (IQR) 28–34] 
vs. 27 (IQR 25–30; p value = 0.02) for non-LS USD. Of 
note, there were no statistically significant differences in 
baseline characteristics, IPSS scores, or procedural history 
for those patients with urine samples ultimately included 
vs. not included.
Patients underwent full diagnostic work-up for USD. 
Treatment elected by patients ultimately included in the 
study included: 38% excision and primary anastomosis/non-
transecting urethroplasty, 24% buccal graft urethroplasty, 
16% direct visual internal urethrotomy (DVIU), and 22% 
conservative management for their disease. Among LS-USD 
patients, 30.1% underwent urethroplasty, 23.0% underwent 
phalloplasty and panniculectomy, 23.0% underwent DVIU, 
and 23.0% used calibration and steroid cream alone as ther-
apy. There was a significant difference in stricture location 
for LS-USD patients versus non-LS USD patients, with 
a predominance of bulbar strictures in the non-LS group. 
(Table 1).
Mean microbiome richness was low and trended 
towards being lower in non-LS USD patients (25.9 vs. 
16.8 for LS-USD vs. non-LS USD, respectively; p = 0.076, 
Fig. 2). Mean Faith’s phylogenetic diversity (taxon rich-
ness) also trended lower 4.23 vs. 3.05 (LS-USD and 
non-LS USD, respectively; p = 0.058) in patients without 
underlying LS (Fig. 1). Though not statistically signifi-
cant based on predetermined cutoffs, these data suggest 
that LS-USD is associated with the presence of a greater 
number of types of bacterial in urine samples.
To assess whether relationships existed between urine 
microbiota and clinical phenotype, unweighted and 
weighted UniFrac distance matrices (metric for comparing 
biological communities) were constructed and analyzed. 
We did not find a significant relationship between LS-
USD and non-LS USD patient microbiota (Supplemental 
Table 1). In contrast, microbiota richness was strongly and 
significantly related to urine microbiota suggesting that the 
observed variation in community structure was primarily 
driven by the number of types of bacteria detected rather 
than the presence or absence of LS.
Since it is likely that the majority of organisms detected 
in the urine of USD patients are common to both LS- and 
non-LS patients, and that LS may be associated with 
expansion of a small number of specific bacteria, we next 
performed comparison of organisms detected between 
LS- and non-LS patients. Patients with LS-USD exhib-
ited enrichment of Sneathia, Lactobacillus, and Tissiere-
llaceae while Staphylococcus, Facklamia, and Dialister 
were enriched in urine samples of patients with non-LS 
USD (Figs. 2, 3).
Table 1  Demographic and medical characteristics of patients with 
USD stratified by LS status
USD urethral stricture disease, LS lichen sclerosis, BMI body mass 
index, IQR interquartile range
Cases 
(LS-USD) 
(n = 13)
Controls 
(non-LS USD) 
(n = 37)
p value
Age, median (IQR) 62 (50–68) 56 (46–66) 0.55
BMI, median (IQR) 32 (28–34) 27 (25–30) 0.02
Smoking status, n (%)
 Current smoker 0 3 (9) 0.32
 Former 3 (23) 12 (35)
 Never 10 (77) 19 (56)
Location of stricture 0.01
 Meatus 5 (38) 3 (8)
 Penile 3 (23) 2 (5)
 Pan-urethral 5 (38) 2 (5)
 Bulbar 0 25 (68)
Previous dilations, median 
(IQR)
1 (0–3) 1 (0–2) 0.76
Previous urethroplasty, 
n (%)
3 (27) 14 (47) 0.25
IPSS total, median (IQR) 7.5 (5.5–15) 12 (8.5–21) 0.22
Antibiotics > 2 months 
prior to inclusion, n (%)
7 (53.9) 9 (24.3) 0.08
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Discussion
To our knowledge, this is the first study of the urinary 
microbiome in patients with USD and specifically, LS. 
In the USD population, urine was enriched with unique 
bacterial communities. Based on our data, the microbiota 
of LS-USD patients appears to house greater bacterial 
diversity compared with patients with non-LS USD. Of 
note, the LS-USD group had twice the rate of antibiotic 
exposure than non-LS USD patients, and increased median 
BMI. Strictures associated with genitourinary LS were 
noted in the meatus, penile urethra, and a pan-urethral 
manner vs. our control population wherein bulbar stric-
tures predominated. Though the variance in overall micro-
biota composition was not related to clinical phenotype, 
specific bacteria genera were found to be enriched in the 
urine of patients with LS-USD. These included Sneathia 
and Lactobacillus taxa. While Lactobacillus represents the 
dominant genus in the female vaginal tract, certain Lac-
tobacillis species have been associated with urge inconti-
nence [18]. A unique microbiologic signature of LS could 
lead to the development of non-invasive testing for LS, 
help to explain pathophysiology of the disease, or lend 
itself to targeted intervention. Prior studies in healthy men 
have demonstrated an abundance of Enterobacteriales, 
Fig. 1  Between-group conpari-
son of alpha diversity indices 
indicate that LS-USD patient 
urine harbors a greater number 
of bacterial types and greater 
diversity compared with non-LS 
USD patients
Fig. 2  Microbiome diversity to order taxonomy level, by sample
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specifically Enterobacteriaceae in urine samples [19]. 
A wide range of microbiome composition has been 
reported in small studies to include: Sneathia, Veillonella, 
Corynebacterium, Prevotella, Streptococcus and Urea-
plasma, Corynebacterium, Staphylococcus, and Strepto-
coccus [6, 20]. We note important differences in median 
BMI between LS-USD and non-LS USD groups [21]. 
There is no established normal microbiota signature in the 
male urinary tract stratified by patient BMI with research 
in this area still in its infancy.
The potential clinical and research implications of 
increased microbiota richness of LS are intriguing. LS is 
associated with squamous cell carcinoma and a suitable bio-
marker to aid in identification of malignant potential would 
be of high utility [22]. Alterations to a cell’s microenviron-
ment by local bacteria may explain the pathway between 
inflammation and cancer development [23]. Efforts to iden-
tify unique protein expression profiles of LS are underway, 
but the microbiome itself may be a potential biomarker [13, 
24]. Given the complexity and potential morbidity in obtain-
ing a tissue diagnosis of LS in the urethra, using urine as a 
microbial-based biomarker would be advantageous.
While an infectious etiology of LS has been actively stud-
ied, there is no consensus that bacterial infection is a cause 
[10]. While some groups have implicated Borrelia burgdor-
feri [25], evidence is ultimately poor with an unknown direc-
tion of association. In our cohort, we did not find evidence 
of this bacterium for patients in the LS-USD group. There 
is alternative evidence of a viral cause of LS [13]. Addi-
tionally, how microbiota may inform patients’ USD symp-
tomatology or affect surgical repair is an open question. In 
abdominal surgery, for example, the microbiome may com-
plicate anastomotic healing [26]. In this series, we did not 
correlate microbiological findings with surgical outcomes.
While our exclusion criteria precluded recent proce-
dure or UTI, our patients had frequent prior endoscopic 
interventions in their past. These procedures may reflect 
higher baseline level of bacterial colonization and may 
explain differences in lower urinary tract microbiota than 
those found previously [5, 19, 20]. Alternatively, prior 
procedures may indicate higher rates of remote antibiotic 
exposures and atypical bacterial populations [27]. Patients 
considering surgical and non-surgical LUTS treatment had 
detectable bacteria in specimens 98% of the time, suggest-
ing bacteria may be present in the urinary tract independent 
of prior procedure [2]. Regardless of sexually transmitted 
infection status, Dong et al. detected an average of 18 bac-
terial genera among a group of 32 healthy young men [6]. 
The microbiota of the male urinary tract is certainly more 
complex and nuanced than traditional pre-operative urine 
cultures would suggest [28].
Limitations
LS diagnosis was based on clinical exam findings at their 
initial visit alone and not confirmed by pathologic diagnosis. 
Only 60% of samples underwent successful amplification, 
but there were no differences in demographics between those 
samples that were successful or not so we do not expect 
this would bias our results. This degree of sample loss is 
also in line with prior literature [29, 30]. Our small sample 
size leaves us unable to identify significant differences in 
specific bacterial taxa based on stricture etiology. The effect 
of steroid use (present for 23% of the cohort) has unknown 
impact on the urinary microbiome. This work does not allow 
us to determine causality given the lack of longitudinal data. 
Increased richness in the LS cohort may imply less chance 
of predominance by single organisms; however, the number 
of LS patients in our cohort is quite small (n = 13). While 
LS can present primarily as dermatological condition, our 
patients were referred for urethral stricture disease and we 
did not pursue glans swabs in the study. It is unknown if 
Fig. 3  Microbiome diversity to order taxonomy level, averaged by group
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patients with primary skin changes on the glans or penile 
shaft skin without USD would have detectable differences 
within the urinary microbiome. A small prior study sug-
gested higher detectable rates of bacteria using catheterized 
specimens. Catheterization was not viable given USD and 
we elected to pursue voided samples to aid recruitment [2]. 
In addition, we did not utilize controls for comparison to rule 
out contamination. In addition, the collection of urine mid-
stream may represent the urethral microbiome. The inclusion 
criteria for microbiome studies based on the method of urine 
collection or antibiotic washout period is not standardized 
[29]. Patients with standard urine cultures > 100,000 cfu/
ml were excluded, which may lead to bias in the results. 
Common to patients with USD, ours reported multiple prior 
instrumentations, infections, and/or dilation with catheteri-
zation which could confound results by altering native uri-
nary microbial communities. Finally, the microbiome may 
reflect the local and regional environment of our hospital or 
potentially even patients’ immediate environment or close 
relationships [31, 32].
Despite these limitations, we present the first study on 
the microbiome of patients with USD. Further research on 
the unique microbiome of these patients may lead to earlier 
detection of pathology and a unique avenue of studying the 
pathophysiology of this disease. In particular, this represents 
a novel approach to understand LS-USD.
Conclusion
We identify a discriminatory bacterial signature in the urine 
of patients with LS-USD vs. non-LS USD which requires 
validation in future studies. The implications of the micro-
biome in genitourinary pathology are evolving and further 
research is needed.
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